Susquehanna International Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-68,457
| Closed | -$1.62M | – | 13941 |
|
|
2023
Q4 | $1.62M | Sell |
68,457
-87,596
| -56% | -$1.56M | ﹤0.01% | 5825 |
|
|
2023
Q3 | $2.33M | Buy |
156,053
+37,087
| +31% | +$492K | ﹤0.01% | 4845 |
|
|
2023
Q2 | $1.3M | Sell |
118,966
-1,065,457
| -90% | -$9.92M | ﹤0.01% | 6080 |
|
|
2023
Q1 | $10.3M | Buy |
1,184,423
+782,755
| +195% | +$6.27M | 0.02% | 2407 |
|
|
2022
Q4 | $2.52M | Buy |
401,668
+290,384
| +261% | +$1.1M | ﹤0.01% | 4308 |
|
|
2022
Q3 | $389K | Buy |
+111,284
| New | +$400K | ﹤0.01% | 9132 |
|
|
2022
Q2 | – | Sell |
-36,418
| Closed | -$87K | – | 14542 |
|
|
2022
Q1 | $113K | Buy |
36,418
+25,573
| +236% | +$80.5K | ﹤0.01% | 11819 |
|
|
2021
Q4 | $37K | Buy |
+10,845
| New | +$41.2K | ﹤0.01% | 12687 |
|
|
2021
Q3 | – | Sell |
-76,433
| Closed | -$301K | – | 14085 |
|
|
2021
Q2 | $333K | Sell |
76,433
-35,196
| -32% | -$156K | ﹤0.01% | 10542 |
|
|
2021
Q1 | $507K | Buy |
111,629
+33,506
| +43% | +$180K | ﹤0.01% | 9441 |
|
|
2020
Q4 | $448K | Buy |
+78,123
| New | +$591K | ﹤0.01% | 8521 |
|
|
2020
Q3 | – | Sell |
-275,877
| Closed | -$1.48M | – | 11546 |
|
|
2020
Q2 | $963K | Buy |
275,877
+187,162
| +211% | +$540K | ﹤0.01% | 6018 |
|
|
2020
Q1 | $131K | Buy |
88,715
+2,820
| +3% | +$4.73K | ﹤0.01% | 9112 |
|
|
2019
Q4 | $168K | Buy |
85,895
+9,218
| +12% | +$34.6K | ﹤0.01% | 8876 |
|
|
2019
Q3 | $393K | Buy |
76,677
+48,035
| +168% | +$291K | ﹤0.01% | 7775 |
|
|
2019
Q2 | $205K | Buy |
+28,642
| New | +$324K | ﹤0.01% | 9087 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 10836 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 10996 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 11194 |
|
|
2018
Q2 | – | Sell |
-84,267
| Closed | -$1.05M | – | 11266 |
|
|
2018
Q1 | $1.09M | Buy |
84,267
+31,367
| +59% | +$390K | ﹤0.01% | 5049 |
|
|
2017
Q4 | $487K | Buy |
52,900
+24,610
| +87% | +$210K | ﹤0.01% | 6694 |
|
|
2017
Q3 | $228K | Buy |
28,290
+14,941
| +112% | +$101K | ﹤0.01% | 7817 |
|
|
2017
Q2 | $77K | Buy |
+13,349
| New | +$56.8K | ﹤0.01% | 8792 |
|
|
2016
Q1 | – | Sell |
-25,405
| Closed | -$43K | – | 9989 |
|
|
2015
Q4 | $43K | Buy |
+25,405
| New | +$41.4K | ﹤0.01% | 9129 |
|
|
2015
Q2 | – | Sell |
-54,108
| Closed | -$374K | – | 10675 |
|
|
2015
Q1 | $374K | Buy |
+54,108
| New | +$520K | ﹤0.01% | 7613 |
|